Therapeutic Areas
Our Innovative Services and Experience Across Therapeutic Areas
Discover how smarter, adaptive clinical trial design can accelerate development, reduce costs, and improve outcomes. Berry Consultants is a global leader in adaptive clinical trial design, leveraging Bayesian analysis and custom trial simulation to create more efficient, data-driven studies for drugs, biologics, and medical devices. From early-phase exploration to pivotal trials, our evidence-based approach supports better decisions at every stage.
We have experience working on clinical trials across the FDA’s therapeutic areas, including many different syndromes, diseases, and other chronic and communicable conditions. Below is a summary of just some of the areas we have constructed adaptive designs in, with many others in progress.
Additional Areas
Services We Can Provide to All Theraputic Areas
Adaptive and fixed designs
Bayesian Drug Development
Bayesian hierarchical modeling
Bayesian meta-analysis, including network meta-analysis
Bayesian survival analysis
Clinical trial simulation
Creating formal study protocol
Decision analysis and development strategies
Develop custom statistical software for designs
Dose escalation and dose finding
Experience with FDA and EMA, and presenting to advisory panels
Longitudinal models for early endpoints, biomarkers, etc.
Predict outcomes of trials comparing new and/or existing therapies
Provide adaptive and Bayesian clinical trial training
Randomized Controlled Trial
Report to and participate on Data Monitoring Committees
Statistical programming and software development
Support and design trials for grant-funded programs and groups
“Bridging” trials that share a single arm